Search results for "protein"

showing 10 items of 21431 documents

Cellular Concentrations of the Transporters DctA and DcuB and the Sensor DcuS of Escherichia coli and the Contributions of Free and Complexed DcuS to…

2017

ABSTRACT In Escherichia coli , the catabolism of C 4 -dicarboxylates is regulated by the DcuS-DcuR two-component system. The functional state of the sensor kinase DcuS is controlled by C 4 -dicarboxylates (like fumarate) and complexation with the C 4 -dicarboxylate transporters DctA and DcuB, respectively. Free DcuS (DcuS F ) is known to be constantly active even in the absence of fumarate, whereas the DcuB-DcuS and DctA-DcuS complexes require fumarate for activation. To elucidate the impact of the transporters on the functional state of DcuS and the concentrations of DcuS F and DcuB-DcuS (or DctA-DcuS), the absolute levels of DcuS, DcuB, and DctA were determined in aerobically or anaerobic…

0301 basic medicine030106 microbiologyBiologymedicine.disease_causeMicrobiologyDNA-binding proteinMass Spectrometry03 medical and health sciencesFumaratesTranscriptional regulationmedicineEscherichia coliDicarboxylic AcidsAnaerobiosisPhosphorylationMolecular BiologyTranscription factorEscherichia coliDicarboxylic Acid TransportersCatabolismKinaseEscherichia coli ProteinsAutophosphorylationGene Expression Regulation BacterialAerobiosisDNA-Binding Proteins030104 developmental biologyBiochemistryPhosphorylationProtein KinasesSignal TransductionTranscription FactorsResearch ArticleJournal of bacteriology
researchProduct

Chromosome-Encoded Hemolysin, Phospholipase, and Collagenase in Plasmidless Isolates of Photobacterium damselae subsp. damselae Contribute to Virulen…

2017

ABSTRACT Photobacterium damselae subsp. damselae is a pathogen of marine animals, including fish of importance in aquaculture. The virulence plasmid pPHDD1, characteristic of highly hemolytic isolates, encodes the hemolysins damselysin (Dly) and phobalysin (PhlyP). Strains lacking pPHDD1 constitute the vast majority of the isolates from fish outbreaks, but genetic studies to identify virulence factors in plasmidless strains are scarce. Here, we show that the chromosome I-encoded hemolysin PhlyC plays roles in virulence and cell toxicity in pPHDD1-negative isolates of this pathogen. By combining the analyses of whole genomes and of gene deletion mutants, we identified two hitherto uncharacte…

0301 basic medicine030106 microbiologyVirulenceGenetics and Molecular BiologyBiologyHemolysin ProteinsApplied Microbiology and BiotechnologyMicrobiology03 medical and health sciencesFish DiseasesHemolysin ProteinsPlasmidAnimalsCollagenasesPathogenEcologyVirulencePhotobacteriumHemolysinChromosomes BacterialPhotobacteriumbiology.organism_classification030104 developmental biologyPhotobacterium damselaePhospholipasesBassGram-Negative Bacterial InfectionsLecithinaseFood ScienceBiotechnologyPlasmidsApplied and environmental microbiology
researchProduct

Perspectives of lupine wholemeal protein and protein isolates biodegradation

2018

Lupine (Lupinus angustifolius L.) protein (in wholemeal and protein isolates) was biodegraded using Pediococcus acidilactici in submerged and solid‐state fermentation conditions. The changes in the molecular weight of lupine protein fractions, amino acid (AA) profile, biogenic amine formation, antimicrobial and antioxidant properties, and protein digestibility in vitro and in vivo (in Wistar rats) were evaluated. After biotreatment, lower molecular weight peptides (from 10 to 20 kDa) were established, and the free AA content increased. Biodegradation improved the antioxidant properties, modulated the antimicrobial properties, and led to higher in vitro and in vivo digestibility and function…

0301 basic medicine030109 nutrition & dieteticsAntioxidantbiologyChemistrymedicine.medical_treatmentfood and beveragesPediococcus acidilactici04 agricultural and veterinary sciencesBiodegradationbiology.organism_classification040401 food scienceIndustrial and Manufacturing EngineeringCaecum03 medical and health sciencesLupinus angustifolius0404 agricultural biotechnologySolid-state fermentationPlant proteinmedicineFermentationFood scienceFood ScienceInternational Journal of Food Science & Technology
researchProduct

Safe intake of a plant sterol-enriched beverage with milk fat globule membrane: Bioaccessibility of sterol oxides during storage

2018

Abstract Sterols in foods are susceptible to oxidation to form oxysterols. It is interesting for consumer health to know real intake and the possible associated adverse effects associated to oxysterols. This study measured oxysterol formation and bioaccessibility (BA) in a plant sterol (PS)-enriched milk-based fruit beverage with milk fat globule membrane (MFGM) added at 0, 3 and 6 months of storage at room temperature. The same cholesterol (COPs) and phytosterol oxidation products (POPs) (exclusively from β-sitosterol) (7α/β-hydroxy, α/β-epoxy, triol and 7-keto) were detected in the beverage and its bioaccessible fraction. Total COPs and POPs contents were maintained during storage, and th…

0301 basic medicine030109 nutrition & dieteticsOxysterolChemistryCholesterolPhytosterolFood composition data04 agricultural and veterinary sciencesPlant sterol040401 food scienceSterol03 medical and health scienceschemistry.chemical_compound0404 agricultural biotechnologyMembranepolycyclic compoundslipids (amino acids peptides and proteins)Food scienceMilk fat globuleFood ScienceJournal of Food Composition and Analysis
researchProduct

Fermentation in fish and by-products processing: an overview of current research and future prospects

2020

Fish industry has been growing continuously over the last decades and generates huge amounts of by-products. These by-products come from fish head, skin, bones, thorns, and viscera. Part of them are processed for feed, collagen and oil production, and to a lesser extent to produce biofuels and fertilizers, but many other high-value bioactive compounds can be recovered. Fish fermentation, which is traditionally used to increase fish shelf-life, results into the formation of bacteria metabolites of interest. Applied to by-products, fermentation increases the quality of protein hydrolysates, oil and produces antioxidant compounds. This technology, which is safe, environmental-friendly and poor…

0301 basic medicine030109 nutrition & dieteticsfood and beverages04 agricultural and veterinary sciencesPulp and paper industry040401 food scienceApplied Microbiology and Biotechnology03 medical and health sciences0404 agricultural biotechnologyBiofuelOil productionEnvironmental scienceFish <Actinopterygii>FermentationProtein hydrolysatesFish headFood ScienceCurrent Opinion in Food Science
researchProduct

2021

Lipids contained in the plasma membrane of platelets play an important role in platelet function. Modifications in the lipid composition can fluidify or rigidify the environment around embedded receptors, in order to facilitate the access of the receptor by the drug. However, data concerning the lipid composition of platelet plasma membrane need to be updated. In addition, data on the impact of drugs on plasma membrane composition, in particular antiplatelet agents, remain sparse. After isolation of platelet plasma membrane, we assessed, using lipidomics, the effect of ticagrelor, a P2Y12 antagonist, and its active metabolite on the lipid composition of these plasma membranes. We describe t…

0301 basic medicine030204 cardiovascular system & hematologyCatalysisInorganic Chemistry03 medical and health scienceschemistry.chemical_compound0302 clinical medicineP2Y12PhosphatidylcholineLipidomicsmedicinePlateletPhysical and Theoretical ChemistryLipid bilayerMolecular BiologySpectroscopyActive metaboliteOrganic ChemistryGeneral MedicineComputer Science Applications030104 developmental biologyMembraneBiochemistrychemistrylipids (amino acids peptides and proteins)Ticagrelormedicine.drugInternational Journal of Molecular Sciences
researchProduct

Recombinant factor VIII: past, present and future of treatment of hemophilia A.

2018

The development of recombinant factor VIII (rFVIII) was initially driven by the necessity to treat hemophilia A (HA) patients with FVIII concentrates without the risk of transmitting infectious agents. Over the last three decades the safety of rFVIII has been further improved by completely removing animal or human proteins from the manufacturing process, so that patients would not be exposed to known or emerging pathogens. Recent efforts have concentrated on improving the expression of rFVIII, reducing its immunogenicity and enhancing its pharmacokinetic (PK) behavior. These new goals have been possible thanks to the develop-ment of biotechnology and a better knowledge of the function and s…

0301 basic medicine030204 cardiovascular system & hematologyPharmacologyStandard half-life FVIIIHemophilia ARecombinant factor viiiHemostaticslaw.inventionCoagulation factor disorder03 medical and health sciences0302 clinical medicineHemostaticlawExtended half-life FVIIIMedicineHumansPharmacology (medical)Mode of actionPharmacologyFactor VIIIbiologybusiness.industryManufacturing processImmunogenicityHuman cellRecombinant ProteinRecombinant FVIIIRecombinant Proteins030104 developmental biologyTreatment OutcomeConsumer Product Safetybiology.proteinRecombinant DNAPEGylationAntibodybusinessDrug ContaminationHumanHalf-LifeDrugs of today (Barcelona, Spain : 1998)
researchProduct

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

2017

Background: Experimental and clinical data suggest that reducing inflammation without affecting lipid levels may reduce the risk of cardiovascular disease. Yet, the inflammatory hypothesis of atherothrombosis has remained unproved. Methods: We conducted a randomized, double-blind trial of canakinumab, a therapeutic monoclonal antibody targeting interleukin-1β, involving 10,061 patients with previous myocardial infarction and a high-sensitivity C-reactive protein level of 2 mg or more per liter. The trial compared three doses of canakinumab (50 mg, 150 mg, and 300 mg, administered subcutaneously every 3 months) with placebo. The primary efficacy end point was nonfatal myocardial infarction, …

0301 basic medicine030204 cardiovascular system & hematologylaw.invention0302 clinical medicinec-reactive proteinRandomized controlled triallawCardiovascular Diseasemiddle ageddouble-blind methodantibodiesMyocardial infarctionhumansStrokeinterleukin-1betabiologyAntibodies MonoclonaldrugGeneral MedicineLipidAged; anti-inflammatory agents; antibodies; monoclonal; antibodies; monoclonal; humanized; atherosclerosis; c-reactive protein; cardiovascular diseases; dose-response relationship; drug; double-blind method; female; humans; incidence; infections; interleukin-1beta; lipids; male; middle aged; myocardial infarction; neutropenia; secondary prevention; strokestrokeAnti-Inflammatory AgentagedEditorialfemalemyocardial infarctionAtherosclerosiMonoclonalsecondary preventionHumanmedicine.drugmedicine.medical_specialtymonoclonalNeutropeniaAntibodies Monoclonal HumanizedInfectionsPlaceboaged; anti-inflammatory agents; antibodies monoclonal; atherosclerosis; c-reactive protein; cardiovascular diseases; dose-response relationship drug; double-blind method; female; humans; incidence; infection; interleukin-1beta; lipids; male; middle aged; myocardial infarction; neutropenia; secondary prevention; stroke; medicine (all)anti-inflammatory agentsdose-response relationshiplipids03 medical and health sciencesmaleInternal medicinemedicineneutropeniamedicine (all)Dose-Response Relationship Drugbusiness.industryAntiinflammatory Therapy Canakinumab for Atherosclerotic DiseaseC-reactive proteinmedicine.diseaseinfectioncardiovascular diseasesSurgeryCanakinumab030104 developmental biologyincidencebiology.proteinatherosclerosisbusinessNew England journal of medicine
researchProduct

Phosphorylation of CENP-A on serine 7 does not control centromere function.

2019

CENP-A is the histone H3 variant necessary to specify the location of all eukaryotic centromeres via its CENP-A targeting domain and either one of its terminal regions. In humans, several post-translational modifications occur on CENP-A, but their role in centromere function remains controversial. One of these modifications of CENP-A, phosphorylation on serine 7, has been proposed to control centromere assembly and function. Here, using gene targeting at both endogenous CENP-A alleles and gene replacement in human cells, we demonstrate that a CENP-A variant that cannot be phosphorylated at serine 7 maintains correct CENP-C recruitment, faithful chromosome segregation and long-term cell viab…

0301 basic medicine1.1 Normal biological development and functioningScience[SDV]Life Sciences [q-bio]CentromereGeneral Physics and Astronomy02 engineering and technology[SDV.BC]Life Sciences [q-bio]/Cellular Biologymacromolecular substancesBiologyGeneral Biochemistry Genetics and Molecular BiologyArticleSerineChromosome segregation03 medical and health sciencesHistone H3Underpinning researchCentromereGeneticsHumansViability assayPhosphorylationlcsh:ScienceComputingMilieux_MISCELLANEOUSCancerGene EditingMultidisciplinaryQGene targetingGeneral Chemistry021001 nanoscience & nanotechnologyCell biologySettore BIO/18 - Genetica030104 developmental biologyChromosome segragationHela CellsPhosphorylationEpigeneticslcsh:QGeneric health relevance0210 nano-technologyFunction (biology)Centromere Protein AHumanHeLa CellsNature communications
researchProduct

The protein and microRNA cargo of extracellular vesicles from parasitic helminths – current status and research priorities

2020

Helminth parasites have a remarkable ability to persist within their mammalian hosts, which is largely due to their secretion of molecules with immunomodulatory properties. Although the soluble components of helminth secretions have been extensively studied, the discovery that helminths release extracellular vesicles (EVs) has added further complexity to the host-parasite interaction. Whilst several studies have begun to characterise the molecules carried by helminth EVs, work aimed at investigating their biological functions has been hindered by a lack of helminth-specific EV markers. To begin to address this, we summarised helminth EV literature to date. With a focus on the protein and mi…

0301 basic medicine10078 Institute of ParasitologyPARASITES2405 ParasitologyHelminthiasisPROTEINExosomes//purl.org/becyt/ford/1 [https]0302 clinical medicine600 TechnologyCladeMICROVESICLESProtein.MicroRNAHelminth ProteinsInfectious DiseasesMicrovesiclesProtein family030231 tropical medicine610 Medicine & healthBiologyCARGO03 medical and health sciencesExtracellular VesiclesHelminthsmicroRNAparasitic diseasesHelminthsAnimalsHumansParasites//purl.org/becyt/ford/1.6 [https]EXOSOMESMICRORNAEXTRACELLULAR VESICLES2725 Infectious Diseasesbiology.organism_classificationMicrovesiclesBiomarker (cell)MicroRNAs030104 developmental biologyNematodeEvolutionary biology570 Life sciences; biologyHELMINTHSParasitologyRNA HelminthFunction (biology)BiomarkersCargo
researchProduct